Royalty Pharma plc (RPRX) has 193 open-market insider trades by 36 insiders since 2002. The most active filer is George W. Lloyd, CLO & VP.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Adage Capital Advisors, L.L.C. | 10% Owner | — | 1 | $320.7M | 2020-12-18 |
| Rory B. Riggs | Dir | — | 17 | $265.2M | 2024-02-20 |
| Mario Germano Giuliani | Dir10% Owner | — | 6 | $120.6M | 2023-12-28 |
| Avara Management Ltd | Dir10% Owner | — | 6 | $112.6M | 2023-12-29 |
| George W. Lloyd | CLOVP | — | 21 | $108.7M | 2025-12-18 |
| ADAGE Capital Partners Gp, LLC | 10% Owner | — | 1 | $84.0M | 2020-06-18 |
| GG 1978 SICAF SIF S.A. - GG Strategic | 10% Owner | — | 2 | $64.1M | 2022-09-19 |
| GG 1978 SICAF SIF S.a. | 10% Owner | — | 3 | $51.3M | 2022-09-20 |
| James F. Reddoch | CSOVP | — | 12 | $43.0M | 2022-09-28 |
| William E. Ford | Dir | — | 1 | $42.0M | 2021-06-30 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Marshall Urist | VP | Sell | $236K | 2026-10-05 |
| Marshall Urist | VP | Sell | $239K | 2026-09-28 |
| Christopher Hite | Chairman & VP | Sell | $5.9M | 2026-09-22 |
| Christopher Hite | Chairman & VP | Sell | $6.0M | 2026-08-18 |
| Terrance P. Coyne | CFO & VP | Sell | $646K | 2026-08-13 |
| Marshall Urist | VP | Sell | $508K | 2026-07-01 |
Companies that share insiders with RPRX, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Christopher Hite | Chairman & VP | Sell | $7.3M | 2026-06-30 |
| Marshall Urist | VP | Sell | $502K | 2026-06-24 |
| Christopher Hite | Chairman & VP | Sell | $8.2M | 2026-06-23 |
| Terrance P. Coyne | CFO & VP | Sell | $3.5M | 2026-05-26 |
| Marshall Urist | VP | Sell | $722K | 2026-05-20 |
| Gregory Norden | Director | Sell | $161K | 2026-05-14 |
| Marshall Urist | VP | Sell | $726K | 2026-05-14 |
| Terrance P. Coyne | CFO & VP | Sell | $1.7M | 2026-04-28 |
| Terrance P. Coyne | CFO & VP | Sell | $1.7M | 2026-04-01 |